Effects of Chloroquine on Patients with Cutaneous Porphyria of the “Symptomatic” Type*

Sweeney, G. D.; Saunders, S. J.; Dowdle, E. B.; Eales, L.
May 1965
British Medical Journal;5/15/1965, Vol. 1 Issue 5445, p1281
Academic Journal
No abstract available.


Related Articles

  • Drugs and porphyria. Magnus, I.A. // British Medical Journal (Clinical Research Edition);5/19/1984, Vol. 288 Issue 6429, p1474 

    Focuses on the acute systemic reactions of patients with porphyria to drugs. Symptoms of porphyria; Types of porphyria; Description of acute intermittent porphyria.

  • Treatment of the Porphyrias: Mechanisms of Action. Bickers, David R. // Journal of Investigative Dermatology;Jul81, Vol. 77 Issue 1, p107 

    The porphyrias are diseases that result from inherited or acquired abnormalities of porphyrin-heme synthesis in the liver and the bone marrow. Only the hepatic porphyrias are known to be aggravated by exposure to a variety of exogenous drugs and chemicals. Simple avoidance of these agents will...

  • A Mutation (G281E) of the Human Uroporphyrinogen Decarboxylase Gene Caused Both Hepatoerythropoietic Porphyria and Overt Familial Porphyria Cutanea Tarda: Biochemical and Genetic Studies on Spanish Patients. Roberts, Andrew G.; Elder, George H.; de Salamanca, Rafael E.; Herrero, Carmen; Lecha, Mario; Mascaro, Jose M. // Journal of Investigative Dermatology;Apr95, Vol. 104 Issue 4, p500 

    Hepatoerythropoietic porphyria is a severe cutaneous porphyria caused by deficiency of uroporphyrinogen decarboxylase and is considered to be the homozygous form of familial (type II) porphyria cutanea tarda. To elucidate further the relation between these conditions, we studied five Spanish...

  • Peginterferon-α-2b/ribavirin.  // Reactions Weekly;6/4/2005, Issue 1054, p13 

    Discusses research being done on the development of porphyria cutanea tarda during treatment with peginterferon-&α-2b and ribavirin. Reference to a study by T. Thevenot and colleagues published in the April 2005 issue of the "Journal of Hepatology"; Outcome of the performance of skin biopsy...

  • Cutaneous Porphyrias: Causes, Symptoms, Treatments and the Danish Incidence 1989-2013. CHRISTIANSEN, Anne L.; AAGAARD, Lise; KRAG, Aleksander; RASMUSSEN, Lars M.; BYGUM, Anette // Acta Dermato-Venereologica;Nov2016, Vol. 96 Issue 7, p868 

    Porphyrias are rare diseases caused by altered haem synthesis leading to the accumulation of different haem intermediates. Neurovisceral attacks may occur in acute porphyrias, while photosensitivity is the presenting symptom in cutaneous porphyrias. We present here an overview of symptoms and a...

  • Why Does This Belly Ache? Grim, Pamela // Discover;Apr2002, Vol. 23 Issue 4, p24 

    Examines the effect of the porphyria in the abdomen. Symptoms of porphyria; Inspection of the urine; Cause of porphyria.

  • Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases. Deen, Kristyn; Wu, Jason // Case Reports in Dermatology;May-Aug2015, Vol. 7 Issue 2, p129 

    Porphyria cutanea tarda (PCT) is the most common type of porphyria worldwide and is often initially diagnosed when cutaneous manifestations arise. We present two patients where misdiagnosis of PCT occurred due to the condition masquerading as epidermolysis bullosa acquisita histologically. In...

  • Hepatocellular Carcinoma in Variegate Porphyria: A Serious Complication. Schneider-Yin, Xiaoye; Van Tuyll Van Serooskerken, Anne-Moon; Went, Philip; Tyblewski, Wojciech; Poblete-Gutterrez25, Pamela; Minder, Elisabeth I.; Frank, Jorge // Acta Dermato-Venereologica;2010, Vol. 90 Issue 5, p512 

    Variegate porphyria is an acute hepatic porphyria resulting from a partial deficiency of protoporphyrinogen oxidase, the penultimate enzyme in haem biosynthesis. Cutaneous symptoms and acute neurovisceral attacks are well-known clinical characteristics of the disease. Less studied, however, is...

  • Adult-onset congenital erythropoietic porphyria (Günther's disease) presenting with thrombocytopenia. Murphy, A.; Gibson, G.; Elder, G. H.; Otridge, B. A.; Murphy, G. M. // Journal of the Royal Society of Medicine;Jun1995, Vol. 88 Issue 6, p357P 

    Cutaneous signs of Gunther's disease (congenital erythropoietic porphyria) developing 5 years after the onset of symptomatic thrombocytopenia are described in a 65-year-old man. Persistent thrombocytopenia unresponsive to corticosteroids and immunoglobulin necessitated a splenectomy.

  • Severe Mucocutaneous Necrotizing Vasculitis Associated with the Combination of Chloroquine and Proguanil. Luong, Minh Son; Bessis, Didier; Raison-Peyron, Nadia; Pinzani, Véronique; Guilhou, Jean-Jacques // Acta Dermato-Venereologica;Mar2003, Vol. 83 Issue 2, p141 

    Presents case report of a 49-year-old man diagnosed with severe cutaneous necrotizing vasculitis induced by Savarine, a combination of chloroquine and proguanil. Type of eruptions that occurred after 13 days of treatment with Savarine and chloroquine; Observations made from the clinical...


Other Topics